TheraLode™


UN&UP’s TheraLode technology greatly improves thrombolysis by overcoming natural blood flow barriers preventing thrombolytic agents from reaching the clot, while accelerating clot lysis using 250X lower thrombolytic doses. Taken together, the technology promises to more safely and effectively lyse clots faster so that 10X more stroke patients can be treated.

learn more

Contact UN&UP for more information